"Concerns persist regarding tactics that some authors continue to use (knowingly or unknowingly) in order to get their trial reports into the publication pipeline. We are disappointed that these highly questionable practices continue. In some cases, we are dealing with quite blatant inaccuracies." - Jane Noyes, Journal of Advanced Nursing
https://onlinelibrary.wiley.com/doi/10.1111/jan.15620
HT #Transparimed on 🐦
Medienhinweis: Mehr Transparenz für klinische Studien - Expertenrunde von TranspariMED online am Donnerstag.
Während in GB und anderen Ländern das Verfahren für Studien-Registrierungen bereits umgestellt ist/wird, hinkt Deutschland immer noch hinterher. Die Pharma-Industrie und insbesondere Medizinprodukte-Hersteller können so weiter unvorteilhafte Studien-Ergebnisse verschleppen.
"For example, a recent study of German university trials found that 29% had never made their results public, wasting public money, slowing down scientific progress, and undermining public health."
https://www.transparimed.org/single-post/germany-clinical-trials
A live discussion hosted by Concilium Scientific on 26 January at 15:30 Berlin time is bringing together some of the key players involved in developing the UK’s pioneering system to discuss with experts how this model could be applied to Germany and other countries. Readers of the TranspariMED blog are warmly invited to join the debate and contribute their ideas. Spaces are limited. Register here: https://mailchi.mp/consilium-scientific/ox1tcyuz9i Learning from the UK experience The UK is the fi
UKRIO
MEZIS e.V.